ArticleHemaSphere2024

High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma.

Maeve A O'Reilly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.